| Elizabeth J Harris, MD | |
|
6272 S Highland Dr, Murray, UT 84121-2126 | |
| (801) 871-6200 | |
| Not Available |
| Full Name | Elizabeth J Harris |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 6272 S Highland Dr, Murray, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518934793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 10722037-1205 (Utah) | Primary |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
The drug pregabalin administered before and after knee replacement surgery, significantly decreased patient pain while increasing and expediting mobility after surgery, according to a study by Asokumar Buvanendran, MD, director of Orthopedic Anesthesia and associate professor of Anesthesiology at Rush University Medical Center, Chicago.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
One point of discussion is the best approach to imaging infected patients, because computed tomography (CT) scanning, the gold standard method for chest imaging, can spread infection due to the need to transport the patient to specialized facilities.
Infants born with complex congenital heart disease are not only at risk for serious heart-related complications, but also for developing a deadly bowel disease, regardless of the type of surgical intervention they receive for their heart. These are the findings from a study by Nationwide Children's Hospital, and appearing in Pediatric Critical Care Medicine published online May 6 ahead of print.
Scientists from Rice University, Baylor College of Medicine and other institutions are using synthetic biology to capture elusive, short-lived snippets of DNA that healthy cells produce on their way to becoming cancerous.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth J Harris, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: () - | Elizabeth J Harris, MD 6272 S Highland Dr, Murray, UT 84121-2126 Ph: (801) 871-6200 |
News Archive
The drug pregabalin administered before and after knee replacement surgery, significantly decreased patient pain while increasing and expediting mobility after surgery, according to a study by Asokumar Buvanendran, MD, director of Orthopedic Anesthesia and associate professor of Anesthesiology at Rush University Medical Center, Chicago.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
One point of discussion is the best approach to imaging infected patients, because computed tomography (CT) scanning, the gold standard method for chest imaging, can spread infection due to the need to transport the patient to specialized facilities.
Infants born with complex congenital heart disease are not only at risk for serious heart-related complications, but also for developing a deadly bowel disease, regardless of the type of surgical intervention they receive for their heart. These are the findings from a study by Nationwide Children's Hospital, and appearing in Pediatric Critical Care Medicine published online May 6 ahead of print.
Scientists from Rice University, Baylor College of Medicine and other institutions are using synthetic biology to capture elusive, short-lived snippets of DNA that healthy cells produce on their way to becoming cancerous.
› Verified 2 days ago
Jennifer Lynn Makosky, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dale L Chapman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dr. Paul E Wirkus, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Dr. John B Wall, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Jake C Jones, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5770 S 250 E, Suite 290, Murray, UT 84107 Phone: 801-747-8700 Fax: 801-747-8701 | |
Joseph A Roberts, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 164 E 5900 S, Ste A112, Murray, UT 84107 Phone: 801-262-2673 Fax: 801-269-9894 | |
Dr. Gary Warren Schlichter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 164 E 5900 S, Ste. A112, Murray, UT 84107 Phone: 801-262-2673 Fax: 801-269-9894 |